Company: STAA
Filing Date: 2025-10-09
Form Type: DFAN14A
Source: 0001213900-25-097833
Chunk: 6

Company: STAAR SURGICAL CO
Filing Date: 2025-10-09
Form: DFAN14A
Chunk 6
---
, correlated, aggregated risk” covers a lot of more exciting
possibilities.

Also, though, in some loose sense this is all
right-way risk: The bigger and more systemically important OpenAI’s products turn out to be, (1) the more money it will make and
(2) the more liability risk it will have. You could imagine scenarios in which a small AI lab unleashes a product that wipes out humanity
without even making any money first, but in a world of expensive AI infrastructure they’re not the mostlikely
scenarios. The central scenario is more like “cool chatbot, then lucrative slop feed, then complete integration into all aspects
of government and the military, thenwipe out humanity.” The rough answer to “whom will you sue when AI dominates
humanity” is “the dominant AI company,” so:

Two people with knowledge of the matter
said OpenAI has considered “self insurance”, or putting aside investor funding in order to expand its coverage. The company
has raised nearly $60bn to date, with a substantial amount of the funding contingent on a proposed corporate restructuring.

One of those people said OpenAI had
discussed setting up a “captive” — a ringfenced insurance vehicle often used by large companies to manage emerging risks.
Big tech companies such as Microsoft, Meta and Google have used captives to cover internet-era liabilities such as cyber or social media.

Man that’s a fun job, being the existential
risk actuary for the OpenAI existential risk captive insurer. Come to think of it, another fun job would be the chief investment officer
for the OpenAI captive insurer. Could you get OpenAI to build you good AI models to pick stocks? Could you just trade ahead of OpenAI’s own
investment deals?

STAAR

One way to think about public-company mergers
and acquisitions is that the shareholders of the target company are selling it, and another company or private equity firm is buying it,
and the target company’s management are the brokers. The deal only gets done if the buyer and the shareholders are willing
to buy and sell at the same price, but the buyer and the shareholders do not ordinarily negotiate with each other; the company’s
managers negotiate for them. If the deal gets done, the managers generally get a big fee, in the form of change-of-control payments, accelerated
vesting of stock options, etc. If the deal does not get done, the managers don’t get any special payment and have